<?xml version="1.0" encoding="UTF-8"?>
<root>
    <author>ENA</author>
    <category>Sectors</category>
    <date>2024-07-26 16:25:32</date>
    <fulldesc>&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;strong&gt;New Delhi, Jul 26 (KNN)&lt;/strong&gt; The central government has announced an extension for pharmaceutical and medical device companies to submit mandatory self-declarations regarding ethical marketing practices.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;The new deadline is set for July 31, 2024, giving industry executives additional time to comply with regulations aimed at curbing unethical promotion of drugs and medical devices.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, top executives are required to file undertakings for the fiscal year 2025, assuring their adherence to ethical marketing standards.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;This move is part of the government's efforts to maintain integrity within the healthcare sector.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;The extension comes in response to requests from several companies that reported difficulties in meeting the original deadline.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Industry insiders suggest that this adjustment will provide relief to firms struggling with compliance, as failure to submit the required declarations could have resulted in governmental action.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;The Department of Pharmaceuticals (DoP) oversees this initiative, which is designed to promote transparency and ethical conduct in the marketing of pharmaceutical products and medical devices.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;The self-declaration process is a key component of the UCPMP 2024, reflecting the government's commitment to regulating industry practices.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;This development underscores the ongoing dialogue between the government and the healthcare industry, as both parties work towards establishing a framework that ensures ethical marketing while supporting business operations.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;em&gt;&lt;strong&gt;(KNN Bureau)&lt;/strong&gt;&lt;/em&gt;&lt;/span&gt;&lt;/p&gt;&#13;
</fulldesc>
    <id>38754</id>
    <link>https://knnindia.co.in/news/newsdetails/sectors/government-extends-deadline-for-pharma-industry-ethics-compliance</link>
    <pubDate>2024-07-26 16:25:32</pubDate>
    <source>knnindia.co.in</source>
    <title>Government Extends Deadline For Pharma Industry Ethics Compliance</title>
</root>
